490 related articles for article (PubMed ID: 14711338)
1. Development of prophylactic vaccines for genital and neonatal herpes.
Jones CA; Cunningham AL
Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338
[TBL] [Abstract][Full Text] [Related]
2. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.
Jones CA; Cunningham AL
Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for herpes simplex virus infections.
Koelle DM
Curr Opin Investig Drugs; 2006 Feb; 7(2):136-41. PubMed ID: 16499283
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein-D-adjuvant vaccine to prevent genital herpes.
Stanberry LR; Spruance SL; Cunningham AL; Bernstein DI; Mindel A; Sacks S; Tyring S; Aoki FY; Slaoui M; Denis M; Vandepapeliere P; Dubin G;
N Engl J Med; 2002 Nov; 347(21):1652-61. PubMed ID: 12444179
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.
Stanberry LR
Herpes; 2004 Aug; 11 Suppl 3():161A-169A. PubMed ID: 15319086
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
[TBL] [Abstract][Full Text] [Related]
9. [Herpes simplex virus vaccine studies: from past to present].
Us D
Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
[TBL] [Abstract][Full Text] [Related]
10. Neonatal herpes simplex virus infection.
Cherpes TL; Matthews DB; Maryak SA
Clin Obstet Gynecol; 2012 Dec; 55(4):938-44. PubMed ID: 23090462
[TBL] [Abstract][Full Text] [Related]
11. Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.
Awasthi S; Shaw C; Friedman H
Expert Rev Vaccines; 2014 Dec; 13(12):1475-88. PubMed ID: 25138572
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus infection during pregnancy.
Stephenson-Famy A; Gardella C
Obstet Gynecol Clin North Am; 2014 Dec; 41(4):601-14. PubMed ID: 25454993
[TBL] [Abstract][Full Text] [Related]
13. Pediatrics and herpes simplex virus vaccines.
Rupp R; Rosenthal SL; Stanberry LR
Semin Pediatr Infect Dis; 2005 Jan; 16(1):31-7. PubMed ID: 15685147
[TBL] [Abstract][Full Text] [Related]
14. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.
Evans IA; Jones CA
J Infect Dis; 2002 Jun; 185(11):1550-60. PubMed ID: 12023760
[TBL] [Abstract][Full Text] [Related]
15. Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.
Awasthi S; Belshe RB; Friedman HM
J Infect Dis; 2014 Aug; 210(4):571-5. PubMed ID: 24652496
[TBL] [Abstract][Full Text] [Related]
16. Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
Hoshino Y; Pesnicak L; Dowdell KC; Burbelo PD; Knipe DM; Straus SE; Cohen JI
J Infect Dis; 2009 Oct; 200(7):1088-95. PubMed ID: 19702506
[TBL] [Abstract][Full Text] [Related]
17. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
[TBL] [Abstract][Full Text] [Related]
18. [Natural history of HSV1 and HSV2 infection. Asymptomatic viral excretion. Mother-infant transmission. Indirect transmission].
Morand P
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):577-85. PubMed ID: 12122327
[TBL] [Abstract][Full Text] [Related]
19. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses.
Stanfield BA; Kousoulas KG; Fernandez A; Gershburg E
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452501
[TBL] [Abstract][Full Text] [Related]
20. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.
Kohl S; Charlebois ED; Sigouroudinia M; Goldbeck C; Hartog K; Sekulovich RE; Langenberg AG; Burke RL
J Infect Dis; 2000 Jan; 181(1):335-9. PubMed ID: 10608784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
